However, it was for a long time an enigma why mutations in TP53 had only been observed in about 15-20 % of sporadic osteosarcomas [11, 12], although p53 is inactivated in an additional 10-20 % by amplification and overexpression of MDM2 [13-15]. The gene discussed is MDM2; the disease is osteosarcoma.